BeiGene
BGNE
#977
Rank
NZ$35.90 B
Marketcap
$328.19
Share price
0.49%
Change (1 day)
19.34%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

We have found no dividend yield history for this company